Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos
Motley Fool Money20 Marras 2022

Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos

The big three healthcare companies aren’t paying much attention to Mark Cuban’s new health care venture, Cost Plus Drugs. But their margins could mean a huge opportunity for the new start-up. Chris Hill caught up with Cuban to discuss: - Why he’s able to sell a leukemia drug for thousands of dollars less than competitors - Stocks he bought during the pandemic - Advice for potential NFL owner Jeff Bezos To check out Mark's new business go to www.CostPlusDrugs.com Companies mentioned: WBA, CVS, NFLX, LYV, LVS, AMZN Host: Chris Hill Guest: Mark Cuban Producer: Ricky Mulvey Engineers: Dan Boyd, Austin Morgan, Tim Sparks Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(2130)

Tax-Smart Retirement Planning and the Long-Term Return of Gold

Tax-Smart Retirement Planning and the Long-Term Return of Gold

Before you start socking away money for retirement, you'll need to pick an account type. But choose wisely— because it'll shape your tax bill today and potentially decades from now. Robert Brokamp dis...

24 Tammi 23min

FSD’s Big Week, Abel Makes a Mark on Berkshire, and 24/7 Trading

FSD’s Big Week, Abel Makes a Mark on Berkshire, and 24/7 Trading

Tesla’s robotaxis are finally driving without a safety driver in the front seat (they are reportedly in a chase car) and we discussed the future business models for Tesla. Then, we covered Greg Abel m...

23 Tammi 42min

2026: The Year of the Mega IPOs?

2026: The Year of the Mega IPOs?

It only took us a couple of weeks into 2026, but it appears this year is shaping up to be the year that many of the largest private companies finally go public. It could start sooner than expected as ...

22 Tammi 19min

The Good, The Bad, and the Unknown at Netflix

The Good, The Bad, and the Unknown at Netflix

Netflix reported earnings and results were solid, but guidance left investors wanting more. We discuss what we saw and why Netflix went all-cash for its Warner Bros Discovery bid. We also touch on the...

21 Tammi 22min

The Fast Casual Comeback Tour

The Fast Casual Comeback Tour

Fast casual restaurant stocks were hit hard over the past year, but many have snapped back over the past month. In today’s episode of Motley Fool Money, Emily Flippen is joined by Fool analysts Sanmee...

20 Tammi 22min

TSM or NVDA: Who Ya Got?

TSM or NVDA: Who Ya Got?

Last week, Taiwan Semiconductor (NYSE: TM) put up stellar fourth-quarter numbers, signaling that we've yet to reach peak AI demand. Are we in for another banner year in 2026? Jason Hall, Travis Hoi...

19 Tammi 26min

Interview with Redwire CEO Peter Cannito

Interview with Redwire CEO Peter Cannito

Peter Cannito is the Chairman and CEO of Redwire, a space infrastructure and services company. Motley Fool contributor Lou Whiteman talks with Cannito about the business of space and the business of R...

18 Tammi 20min

What to Know About a Stock’s Workforce

What to Know About a Stock’s Workforce

The largest expense for most companies is labor, so how a company chooses, manages, and pays its workforce can be a crucial consideration when evaluating it as an investment. Robert Brokamp discusses ...

17 Tammi 20min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
rss-rahamania
herrasmieshakkerit
ostan-asuntoja-podcast
taloudellinen-mielenrauha
rss-sami-miettinen-neuvottelija
rahapuhetta
juristipodi
rss-startup-ministerio
rss-paasipodi
rss-draivi
pomojen-suusta
rss-lahtijat
rss-rikasta-elamaa
rss-pinnan-alla-kiehuu
rss-sisalto-kuntoon
rss-seuraava-potilas